Recombinant protein vaccines, which are obtained by conventional genetic engineering, are based on the proteins of target pathogens that can activate our immune systems. Unlike other types of vaccines ...
LONDON--(BUSINESS WIRE)--According to the latest market study released by Technavio, the global veterinary vaccines market is expected to reach USD 6,893.72 million by 2021, growing at a CAGR of ...
insights from industryAmy ShengHead of CROSino Biological In this interview, News-Medical talks to Dr. Amy Sheng, the head of CRO program at Sino Biological US Inc., about current developments in the ...